Table I.
Patient characteristics, duration of surgery and the block level at the end of surgery.
| Group TR (n=48) | Group TRSF (n=49) | Group TRF (n=50) | P-value | |
|---|---|---|---|---|
| Age, years | 27.0±3.4 | 27.8±3.4 | 27.2±4.1 | 0.653 |
| Weight, kg | 68.7±6.8 | 67.9±6.5 | 70.1±6.9 | 0.473 |
| Height, cm | 160.1±4.2 | 159.2±3.6 | 161.2±4.6 | 0.189 |
| Gestational age, weeks | 38.9±1.1 | 38.7±1.6 | 39.1±1.2 | 0.438 |
| Duration of surgery, min | 36.6±8.1 | 37.5±6.8 | 35.8±7.5 | 0.120 |
| Level of sensory block | T6 (4–9) | T6 (4–8) | T5 (4–9) | 0.345 |
Data are presented as the mean ± standard deviation or the median (range). Group TR, TAP block with ropivacaine; group TRSF, TAP block with ropivacaine plus subcutaneous fentanyl; group TRF, TAP block with ropivacaine-fentanyl mixture. TAP, transversus abdominis plane.